Leena Puustinen

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Placebo Controlled

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Heikki Hyöty, Susanna Kääriäinen, Jutta E Laiho, Gail M Comer, Wei Tian, Taina Härkönen, Jussi P Lehtonen, Sami Oikarinen, Leena Puustinen, Michele Snyder, Francisco León, Mika Scheinin, Olli H Laitinen, Miguel Sanjuan
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial. Diabetologia 67 (5) (2024)
Heikki Hyöty, Susanna Kääriäinen, Jutta E Laiho, Gail M Comer, Wei Tian, Taina Härkönen, Jussi P Lehtonen, Sami Oikarinen, Leena Puustinen, Michele Snyder, Francisco León, Mika Scheinin, Olli H Laitinen, Miguel Sanjuan
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial. Diabetologia 67 (5) (2024)
Heikki Hyöty, Susanna Kääriäinen, Jutta E Laiho, Gail M Comer, Wei Tian, Taina Härkönen, Jussi P Lehtonen, Sami Oikarinen, Leena Puustinen, Michele Snyder, Francisco León, Mika Scheinin, Olli H Laitinen, Miguel Sanjuan
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial. Diabetologia 67 (5) (2024)
Heikki Hyöty, Susanna Kääriäinen, Jutta E Laiho, Gail M Comer, Wei Tian, Taina Härkönen, Jussi P Lehtonen, Sami Oikarinen, Leena Puustinen, Michele Snyder, Francisco León, Mika Scheinin, Olli H Laitinen, Miguel Sanjuan
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial. Diabetologia 67 (5) (2024)
Heikki Hyöty, Susanna Kääriäinen, Jutta E Laiho, Gail M Comer, Wei Tian, Taina Härkönen, Jussi P Lehtonen, Sami Oikarinen, Leena Puustinen, Michele Snyder, Francisco León, Mika Scheinin, Olli H Laitinen, Miguel Sanjuan
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial. Diabetologia 67 (5) (2024)
Heikki Hyöty, Susanna Kääriäinen, Jutta E Laiho, Gail M Comer, Wei Tian, Taina Härkönen, Jussi P Lehtonen, Sami Oikarinen, Leena Puustinen, Michele Snyder, Francisco León, Mika Scheinin, Olli H Laitinen, Miguel Sanjuan
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial. Diabetologia (2024)